Komipharm International Co., Ltd. (KOSDAQ:041960)

Komipharm International Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	25,466	12,448	14,820	10,805	11,992	15,048
Short-Term Investments	-	0	-0	-	23.08	2,057
Trading Asset Securities	2,983	10,000	-	-	1,914	-
Cash & Short-Term Investments	28,450	22,448	14,820	10,805	13,929	17,106
Cash Growth	3.61%	51.47%	37.16%	-22.43%	-18.57%	-18.25%
Accounts Receivable	17,504	15,696	12,042	10,849	9,858	10,991
Other Receivables	-	1.34	47.67	25.07	150.49	225.26
Receivables	23,741	21,808	17,901	13,984	12,848	12,963
Inventory	15,338	14,566	14,901	16,254	14,176	13,837
Prepaid Expenses	357.78	181.04	1,723	327.35	183.49	145.63
Other Current Assets	1,086	932.06	667.43	221.76	315.9	624.05
Total Current Assets	68,972	59,935	50,012	41,593	41,452	44,675
Property, Plant & Equipment	55,513	55,784	64,239	66,522	70,141	72,063
Long-Term Investments	1,019	1,010	2,619	1,223	2,220	4,320
Other Intangible Assets	1,729	1,841	42.46	54.76	62.17	68.42
Long-Term Accounts Receivable	-	-	-	-	0	-
Long-Term Deferred Charges	3,183	2,052	1,172	753.46	847.1	616.92
Other Long-Term Assets	3,179	2,128	470.07	1,579	539.54	169.24
Total Assets	133,650	122,767	118,598	111,751	115,262	121,913
Accounts Payable	3,918	5,385	2,615	3,746	2,756	3,367
Accrued Expenses	507.66	309.88	437.59	274.77	329.23	283.02
Short-Term Debt	23,499	33,719	36,731	21,500	19,500	31,043
Current Portion of Long-Term Debt	1,946	829.46	3,531	13,141	731.05	1,731
Current Portion of Leases	161.03	185.04	245.64	174.68	154.46	160.86
Other Current Liabilities	3,872	5,805	8,668	2,211	2,213	2,752
Total Current Liabilities	33,904	46,233	52,228	41,047	25,685	39,338
Long-Term Debt	15,200	8,896	4,326	3,057	12,798	2,519
Long-Term Leases	246.08	209.6	267.91	258.85	237.84	214.54
Long-Term Deferred Tax Liabilities	1,761	1,761	1,761	1,741	1,741	1,741
Other Long-Term Liabilities	7,683	129.27	0	0	2,394	-
Total Liabilities	58,793	57,229	58,583	46,104	42,856	43,812
Common Stock	7,341	7,062	7,060	6,419	6,419	6,419
Additional Paid-In Capital	83,796	69,115	73,874	80,279	78,807	84,993
Retained Earnings	-13,971	-10,670	-23,783	-24,804	-18,290	-13,831
Treasury Stock	-7,737	-5,730	-2,052	-1,989	-989.46	-989.46
Comprehensive Income & Other	2,565	2,504	1,238	725.91	513.98	-315.96
Total Common Equity	71,995	62,280	56,338	60,631	66,460	76,275
Minority Interest	2,863	3,257	3,677	5,016	5,946	1,825
Shareholders' Equity	74,857	65,538	60,015	65,647	72,406	78,101
Total Liabilities & Equity	133,650	122,767	118,598	111,751	115,262	121,913
Total Debt	41,053	43,839	45,102	38,131	33,422	35,668
Net Cash (Debt)	-12,603	-21,391	-30,282	-27,327	-19,493	-18,563
Net Cash Per Share	-179.97	-306.96	-431.66	-388.82	-277.38	-264.39
Filing Date Shares Outstanding	75.24	69.28	70.15	70.12	70.28	70.28
Total Common Shares Outstanding	75.24	69.28	70.15	70.12	70.28	70.28
Working Capital	35,068	13,702	-2,217	545.11	15,768	5,337
Book Value Per Share	956.91	898.99	803.07	864.66	945.70	1085.37
Tangible Book Value	70,266	60,439	56,295	60,576	66,398	76,207
Tangible Book Value Per Share	933.93	872.41	802.46	863.88	944.81	1084.39
Land	14,149	14,149	17,998	17,903	18,678	18,561
Buildings	42,228	42,177	44,444	44,337	44,359	44,029
Machinery	27,200	26,410	25,514	25,146	24,625	24,231
Construction In Progress	10,551	9,894	10,804	10,719	10,719	10,361

Source: S&P Global Market Intelligence. Standard template. Financial Sources.